Losartan
Top View
- Angiotensin Modulators: Angiotensin II Receptor Blockers Review 02/09/2009
- Summary of Product Characteristics 1. Name of The
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- Angiotensin II Receptor Blockers -August 2014
- Efficacy and Safety of Long-Term Losartan Therapy Demonstrated By
- Angiotensin Ii Receptor Antagonist (Arb) Dosing: Tool for Switching Between Agents in Canada
- Evaluation of the Affordable Medicines Programme in Ukraine
- For the Use Only of a Registered Medical Practitioners Or a Hospital Or a Laboratory
- Losartan Monograph
- Valsartan Recall Angiotensin II Receptor Blockers (Arbs) Equivalent Dosing
- Clinical Pharmacokinetics of Angiotensin II (AT1) Receptor Blockers in Hypertension
- The Hypotensive and Uricosuric Effect of Valsartan Compared to Losartan in Gout Patients
- Drug Class Review on Angiotensin II Receptor Antagonists
- Pharmaceutical Benefits Scheme Codes
- Blood Pressure Lowering in Essential Hypertension with an Oral Renin Inhibitor, Aliskiren
- Comparative Antihypertensive Efficacy of Olmesartan
- A Meta-Analysis of Randomized Trials of Telmisartan Versus Losartan for Reduction of Ambulatory Blood Pressure
- Efficacy and Tolerability of Losartan in Patients with Essential Hypertension: a Multicentre, Double-Blind Comparison of Losartan with Metoprolol